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The globus pallidus (GP) plays a key role in the overall basal ganglia (BG) activity. Despite evidence of cholinergic inputs to GP,
their role in the spiking activity of GP neurons has not received attention. We examine the eﬀect of local activation and blockade
of muscarinic receptors (MRs) in the spontaneous ﬁring of GP neurons both in normal and ipsilateral striatum-lesioned rats. We
found that activation of MRs produces heterogeneous responses in both normal and ipsilateral striatum-lesioned rats: in normal
rats the response evoked by MRs depends on the predrug basal ﬁring rate; the inhibition evoked by MRs is higher in normal rats
than in striatum-lesioned rats; the number of neurons that undergo inhibition is lower in striatum-lesioned rats than in normal
rats. Our data suggest that modulation of MRs in the GP depends on the ﬁring rate before their activation and on the integrity of
the striato-pallidal pathway.
1.Introduction
The use of antimuscarinic drugs in the management of Par-
kinson’s disease either as monotherapy or as an adjunct to
otherdrugsis still in wide practice[1,2].Theinitial concepts
of BG function have pointed out to the striatum as the target
of antimuscarinic drugs to relief Parkinsonian motor symp-
toms [3, 4]. However, the presence of MRs modiﬁes the
activity of other BG nuclei [5–7].
The GP plays a key role in the global activity of basal
ganglia [8]. Variations in the basal spontaneous ﬁring rate
of pallidal neurons are related to movement disorders both
in humans and in animal models of Parkinson’s disease
[9, 10]. The eﬀect of a wide variety of neurotransmitters on
the electrical activity of GP neurons has been studied [11–
16], yet, despite the presence of cholinergic ﬁbers in the GP
coming from the pedunculopontine nucleus (PPN) [17–20],
there are no studies on the eﬀect of acetylcholine on the
spiking activity of GP neurons.
Previous works have shown the presence of MRs in the
GP[21,22]butstudiesofinsituhybridizationandsingle-cell
reverse transcription-polymerase chain reaction techniques
have not detected mRNA for MRs in GP neurons. In addi-
tion, mRNA for M1 and M4 receptors has been found in
medium spiny striatal neurons [23–25] projecting to the GP.
In this context, Kayadjanian et al. [26] demonstrated that
activation of MRs increases GABA release in GP rat brain
slices and that this eﬀect could be blocked by a muscarinic
antagonist. These data pointed us to examine the regulation
of GABA release in the GP by presynaptic striato-pallidal
MRs. Therefore, here we analyze the eﬀect of the local acti-
vation and blockade of MRs on the spontaneous spiking
rate of GP neurons in both normal and ipsilateral striatum-
lesioned rats.
2.MaterialandMethods
Experiments were performed on male Wistar rats weighing
180–220g. Rats were maintained and handled according2 The Scientiﬁc World Journal
to the guidelines of the ESM-IPN Animal Care and Use
Committee and followed the Guide for the Care and Use of
LaboratoryAnimalspublishedbytheU.S.NationalInstitutes
of Health.
2.1. Surgery and Drug Application. Rats were anaesthetized
with chloral hydrate (300mg/kg, i.p.; supplemented as
needed) and positioned in a stereotaxic apparatus. A heating
pad and rectal thermometer system was employed to main-
tain body temperature at 36–38◦C. A 4mm burr hole was
drilled in the skull to allow for the stereotactical guide of
glass electrodes and a steel double cannula system (30-gauge
syringe needles) into the right GP. Tips of both cannulas
wereseparated0.1mm.Therecordingelectrodeswereplaced
0.2mm posterior to bregma, 3.0–3.3mm lateral, and 4–
6mm ventral to brain surface according to the atlas of Pax-
inos and Watson [27]. The injection cannulas were placed
at an angle of 70◦ in the latero-medial direction to the fol-
lowing coordinates: 1.1mm posterior to bregma, 5.7mm
lateral, 5.6mm ventral to the brain surface. Bethanechol and
oxotremorine were used as muscarinic agonists. Atropine
was employed as muscarinic antagonist. Tacrine, a selective
acetylcholinesterase inhibitor, was locally applied to disclose
any tonic cholinergic input to the GP. All drugs were pur-
chased from Sigma-Aldrich, USA; drugs were dissolved in
saline 0.9% and infused into the GP using a 1µL syringe. The
piston of the syringe was connected to a precision microm-
eter that allowed an infusion rate of 50nL/15s. The total
volume injected per individual drug infusion was 100nL.
Only neurons with ﬁve minutes of stable baseline ﬁring were
chosen for drug application. For any individual neuron, a
20% change of the baseline ﬁring rate during the minute
following drug infusion was considered signiﬁcant [28]. The
tips of the recording microelectrode and injection cannula
were within a range of not greater than 0.2mm [14].
2.2. Data Acquisition and Analysis. Standard extracellular
recordings were made using glass electrodes (2–6MΩ)ﬁ l l e d
with 2M NaCl solution containing 2% pontamine sky blue
dye. Extracellular signals were ampliﬁed 10,000 X, bandpass
ﬁltered between 0.3 and 3kHz (DAM-80 ampliﬁer; WPI
Saratosa, Fla, USA) and stored on an audiocassette device.
Single-unit activity was isolated using a window discrimi-
nator WPI-121 (WPI Saratosa, Fla, USA). Spike times were
preprocessed online and further analyzed oﬄine using the
INF-386 program for spike data analysis [29]. Statistical
comparisons between or among groups were determined
with Student’s t-test and one-way ANOVA (with Newman-
Keuls post-hoc test) using Prism 3 (GraphPad Software).
Data are expressed as the mean ± standard error or as a per-
centage of the control value (baseline activity).
2.3. Histology. At the end of each recording session, the
level of the studied unit was marked by ejecting pontamine
sky blue from the electrode by passing a 10µAn e g a t i v e
constantcurrentfor20minutes. Afterexperiments, ratswere
given a lethal overdose of pentobarbital and transcardiacally
perfused with 4% formaldehyde. Following overnight incu-
bation in formaldehyde, the brains were sliced (20µm thick
slices) to verify the positions of the recording electrode and
the injection cannulas. When either the recording electrode
or the injection cannulas were not positioned within the GP,
the experiment was discarded.
2.4. Striatal Lesions. Unilateral stereotaxic lesions of the
corpus striatum were made in male Wistar rats (160–170g,
body weight) anaesthetized with chloral hydrate (300mg/kg,
i.p.).A2mmburrholewasdrilledintheskulltoallowforthe
stereotactical guide of a 30-gauge cannula into the striatum.
The stereotaxic coordinates to the striatum were 1.3mm
anterior to bregma, 3mm lateral to midline, and 4.8mm
ventral to dura [27]. The injection cannula was connected
to a manual 5µL Hamilton syringe through a polyethylene
plastic tube. A total of 1µL (120nmol) of quinolinic acid
was infused over 4min. At the end of the manual infusion,
the cannula was left in place for 5 more minutes to improve
solution delivery. Quinolinic acid was ﬁrst dissolved in 4M
NaOH and subsequently titrated with 1N HCl to pH 7.4. A
sham group of rats was prepared using the same procedure.
2.5. Behavioral Testing. To evaluate the lesions, rats were
tested for lesion-induced turning behavior with systemic
application of apomorphine (0.5mg/kg, i.p.) 10 days after
the quinolinic acid lesion. The number of ipsilateral turns
was recorded and only rats showing more than 20 whole-
body turns/10 minutes were considered successfully lesioned
and further used for ipsilateral GP extracellular recordings.
The sham group of rats was also challenged with the same
doseofapomorphine.Inbothsuccessfullylesionedandsham
rats, extracellular recordings of ipsilateral GP neurons were
made 7 days after turning behavior analysis. Single-unit
extracellular recordings were made as previously described
in this work. At the end of each experiment, rats were
given a lethal overdose of pentobarbital and transcardiacally
perfused with 4% formaldehyde. The brains were then
removed and left for overnight incubation. Thereafter, the
brains were sliced (20µm thick slices) to evaluate the striatal
lesionasafunctionoftherightlateralventricleareaaswellas
to properly determine the recording sites and drug injection
cannula trajectories. When either the recording electrode or
the injection cannula was not positioned within the GP, the
experiment was discarded.
3. Results
AllthespikesrecordedinthisstudybelongtotypeIIneurons
(biphasic positive/negative waveforms [28]). The spontane-
ous ﬁring rate of 97 neurons recorded from normal rats
rangedfrom6.3to98.7spikes/s.Theaveragespikingratewas
27.3 ± 2.64 spikes/s.
3.1. Eﬀect of Local Activation of MRs on the Baseline Spiking
Rate. To analyze the eﬀect of the activation of MRs on
the spiking rate of GP neurons in normal rats, we locally
applied diﬀerent doses of bethanechol, a muscarinic agonist.
All doses of bethanechol produced heterogeneous eﬀects
(Table 1). Twenty neurons were recorded in the presence ofThe Scientiﬁc World Journal 3
Table 1: Response of GP neurons to diﬀerent concentrations of
bethanechol.
Increase Decrease No response Total
100pmol 11 (55%) 7 (35%) 2 (10%) 20 (100%)
1nmol 14 (64%) 6 (27%) 2 (9%) 22 (100%)
10nmol 13 (54%) 7 (29%) 4 (17%) 24 (100%)
Values represent n (%).
100pmol bethanechol, 11 (55%) increased their ﬁring rate
by 51.44 ± 3.27%, 7 (35%) diminished their ﬁring rate by
46.05 ± 5.7% and the remaining two neurons did not re-
spond.
Application of 1nmol bethanechol increased the spiking
rate by 94.96 ± 25.78% in 14 out of 22 neurons (64%). Six
outof22neurons(27%)showeda67.39 ±11.37%inhibition
in their ﬁring rate, and the remaining two neurons (9%) did
not respond (Figures 1(b) and 1(d)).
When we applied an infusion of 10nmol bethanechol to
a group of 24 neurons, 13 (54%) increased their ﬁring rate
by 223.47 ± 20.8%, seven (29%) decreased their ﬁring rate
by 79.45 ± 5.5%, and four (17%) did not respond.
The excitatory eﬀe c te v o k e db yb e t h a n e c h o lw a sd o s e -
dependent. 10nmol bethanechol caused signiﬁcant diﬀer-
ences in the ﬁring rate when compared to 100pmol and
1nmol (P<0.05; one-way ANOVA post-hoc test; Figure
1(a)). In addition, the inhibitory eﬀect of bethanechol was
also dose-dependent. 10nmol bethanechol was statistically
diﬀerent compared to 100pmol (P<0.05; one-way ANOVA
post-hoc test; Figure 1(c)).
A detailed analysis of the ﬁring rate before and after local
infusion of 1nmol bethanechol revealed that neurons that
were inhibited had a higher baseline ﬁring rate compared to
neurons that were excited or did not respond to bethanechol
(Figure 2). In the six neurons that were inhibited by 1nmol
bethanechol, their baseline ﬁring rate was 49.51 ± 7.33
spikes/s. In contrast, the baseline spiking rate in neurons that
were excited by (n = 14) or did not respond to (n = 2)
the same concentration of bethanechol was 23.05 ± 5.12 and
17.86 ± 1.48 spikes/s, respectively.
The baseline ﬁring rate in neurons that were inhibited
by 1nmol bethanechol was statistically diﬀerent when com-
pared to the baseline ﬁring rate of neurons that were excited
(P<0.01; t-test). Similarly, in the seven neurons that were
inhibited by 10nmol bethanechol, the baseline ﬁring rate
(54.72 ± 4.33 spikes/s) was higher when compared to the
values of neurons that were exited (20.14 ± 5.49 spikes/s;
P<0.01, t-test). There was no statistically signiﬁcant
diﬀerence between the baseline ﬁring rate of neurons that
were inhibited and those that did not respond to 10nmol
bethanechol.
3.2. Eﬀect of Local Blockade of MRs on the Baseline Spiking
Rate. The eﬀect of the local infusion of 1nmol atropine, an
unspeciﬁc muscarinic antagonist, was tested in 21 neurons.
In 6 out of 21 (33%) neurons, atropine increased the sponta-
neousﬁringrateby163.69±85.5%,inthisgroupofneurons,
the spontaneous ﬁring rate previous to the application of
the antagonist was 27.6 ± 11.32 spikes/s. In eight out of
21 neurons (38%) atropine did not produce signiﬁcant
changes (−4.25 ± 5.09%). In neurons that did not respond
to atropine, the baseline ﬁring rate was 21.68 ± 5.18 spikes/s.
In seven out of 21 neurons (33%), local infusion of atropine
diminished their baseline ﬁring rate by 48.19 ± 10.72%, the
baseline ﬁring rate of this group of neurons before local
application of atropine was 50.97 ± 15.71 spikes/s. There was
not statistically signiﬁcant diﬀerence between the baseline
ﬁring rate of those neurons that were inhibited and those
that did not respond or were excited by atropine (one-way
ANOVA post-hoc test; Figure 3(b)). In some neurons, the
ﬁring rate changes evoked by bethanechol were blocked by
atropine (Figure 3(a)).
3.3. Eﬀect of Local Blockade of Acetylcholinesterase on the
Baseline Spiking Rate. To determine if there is a tonic release
of acetylcholine in the GP, we locally applied tacrine, a
selective inhibitor of acetylcholinesterase. Tacrine (5nmol)
evoked heterogeneous responses in the ﬁring rate of 10 GP
neurons: two (20%) were excited by 58.9 ± 24.42%, four
(40%) were inhibited by 67.38 ± 17.27%, and the remaining
four neurons (40%) did not respond. The baseline spiking
rate in neurons that were inhibited by tacrine was 37.24 ±
7.17 spikes/s, while the baseline ﬁring rate in neurons that
wereexcitedordidnotrespondwas19.85 ±0.21and20.32 ±
0.57 spikes/s, respectively. There were statistically signiﬁcant
diﬀerences between the baseline ﬁring rate of neurons that
were inhibited and those that were exited or did not respond
to tacrine (P<0.01; t-test; Figure 4).
3.4. Eﬀect of Local Activation of MRs by Bethanechol in Rats
withIpsilaterallyDenervatedStriatum. Toanalyzethecontri-
bution of the striato-pallidal pathway on the local responses
evoked by MRs activation, we proceeded to destroy the
ipsilateralstriatumwithquinolicacid.Totestiftheipsilateral
striatum was properly destroyed, we analyzed the rotational
behaviorbyapplyingapomorphine0.5mg/kg(i.p.)oneweek
after the infusion of the neurotoxic.
Rats that presented 20 whole-body turns/10 minutes
were chosen to analyze the spiking activity of GP neurons.
A sham group of four rats was prepared applying the same
volume of saline.
We recorded GP neurons in the ipsilaterally denervated
striatum ﬁve days after the rotational behavior test (Figure
5(a)). The mean baseline ﬁring rate of 28 neurons recorded
in lesioned rats was 22.33 ± 2.1 spikes/s (range: 5.27–
68.6 spikes/s). The local infusion of 1nmol bethanechol
produced heterogeneous eﬀects in GP neurons of lesioned
rats (Table 2). In 19 out of 28 (68%) neurons recorded from
seven lesioned rats, bethanechol increased the ﬁring rate by
102 ± 27%, and only in four (14%) neurons bethanechol
diminished the ﬁring rate by 27.8 ± 3.36%. In the remaining
ﬁve neurons (18%) bethanechol had no eﬀect. Further, 19
neurons were recorded in the sham group. Eleven out of
19 (58%) were excited 87.2 ± 17.3% by the same dose of
bethanechol used in lesioned rats. Five out of 19 neurons
(26%) diminished the basal ﬁring rate by 55.3 ± 9.1%.4 The Scientiﬁc World Journal
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Figure 1: Intrapallidal activation of MRs produces heterogeneous eﬀects on the baseline ﬁring rate of globus pallidus neurons recorded
in normal rats. (a) Bethanechol 100pmol, 1 and 10nmol increases the spiking rate in a dose-dependent manner (∗P<0.05 as compared
to bethanechol 100pmol and 1nmol. One-way ANOVA, Newman-Keuls post-hoc test). (b) Frequency histogram showing the increase
in baseline ﬁring rate induced by local application of 1nmol bethanechol. (c) In another group of globus pallidus neurons, bethanechol
decreases the spiking rate in a dose-dependent manner. (∗P<0.01, as compared to 100pmol bethanechol, one-way ANOVA, Newman-
Keuls post-hoc test). (d) Frequency histogram illustrating the inhibitory eﬀect of 1nmol bethanechol on a pallidal neuron. spks/s, spikes per
second.
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Figure 2: The eﬀect of local activation of MRs depends on the ﬁring rate before the application of diﬀerent doses of bethanechol. (a) Shows
that bethanechol 1nmol produces heterogeneous eﬀects on the spiking rate of globus pallidus neurons depending on the baseline ﬁring
rate before drug application. Only data from six neurons that suﬀered excitation are plotted. (b) Statistics showing that the excitation or
inhibition evoked by 1 and 10nmol bethanechol depends on the predrug baseline ﬁring rate. ∗P<0.01; t-test. spks/s, spikes per second.
The remaining tree neurons (16%) did not respond to be-
thanechol.
In neurons recorded from lesioned rats, the baseline ﬁr-
ing rate of those cells that were inhibited by 1nmol bethane-
col was 22.54 ± 9.27 spikes/s whereas in those that were ex-
citedbyandinthosethatdidnotrespondtobethanecholwas
20.8 ± 3.9 and 22.15 ± 3.22 spikes/s, respectively. There were
no statistically signiﬁcant diﬀerences in the baseline ﬁring
rate of neurons recorded from lesioned rats independently
of the eﬀect of bethanechol. In the sham group of rats, the
baseline spiking rate of the neurons that were inhibited was
48.2 ± 6 spikes/s, whereas in those neurons that were excited
or did not respond, the baseline ﬁring rate was 24 ± 5.3 and
21.5 ± 3.7 spikes/s.
3.5. Diﬀerences in the Response to the Activation of MRs in
ShamandLesionedStriatum. Inshamrats,thebaselineﬁring
rate was higher in neurons that were inhibited by 1nmolThe Scientiﬁc World Journal 5
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Figure 3: The heterogeneous eﬀects in the spiking rate of globus pallidus neurons evoked by local blockade of MRs do not depend on the
ﬁring rate before application of atropine. (a) Frequency histogram of a pallidal neuron showing the blockade of the inhibition evoked by
activation of MRs by atropine. spks/s, spikes per second. (b) Statistics illustrating that the eﬀect of the local blockade of MRs in the spiking
rate does not depend on the baseline ﬁring rate before local infusion of 1nmol atropine.
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Figure 4: The increase in the tonic cholinergic input modiﬁes the ﬁring rate in globus pallidus neurons depending on the baseline ﬁring
rate before application of tacrine. (a) Frequency histogram showing the ﬁring rate inhibition induced by local application of 5nmol tacrine
in a globus pallidus neuron ﬁring at ∼75 spikes/s. (b) Statistics illustrating that the eﬀect of the local blockade of acetylcholinesterase in
the spiking rate depends on the baseline ﬁring rate before local infusion of 5nmol tacrine (∗P<0.01; t-test). spks/s, spikes per second;
NE/Excited, no eﬀect or excitation.
bethanechol than in neurons of lesioned rats that were also
inhibited (P<0.01, t-test; Figure 5(b)). The percent of in-
hibition evoked by 1nmol bethanechol in neurons recorded
in sham rats was higher than the percent of inhibition in
lesioned rats (P<0.01, t-test; Figure 5(c)). There was no
significant diﬀerence in the excitation induced by 1nmol
bethanechol in both groups of rats. The percentage of neu-
rons that were inhibited by the same dose of bethanechol was
lower when compared to sham rats.
3.6. Eﬀect of Oxotremorine on the Spiking Rate of GP Neurons
of Sham and Ipsilaterally Denervated Striatum Rats. Finally,
we analyzed the eﬀect of another muscarinic agonist on the
spontaneous ﬁring rate of GP neurons in both sham and
lesioned rats. We employed oxotremorine because the afﬁn-
ities of bethanechol and oxotremorine for M1 and M4 re-
ceptors are similar [30]. The baseline ﬁring in sham rats and
lesioned rats were 23.6 ± 8.3 and 25.9 ± 1.8 spikes/s, re-
spectively. Oxotremorine (1nmol) produced heterogeneous6 The Scientiﬁc World Journal
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Figure 5: The activation of MRs in the globus pallidus has diﬀerential characteristics between sham and ipsilateral striatum-lesioned rats.
(a) Intraperitoneal application of apomorphine (0.5mg/kg) induces ipsilateral turning behavior in rats with striatal lesion. (∗P<0.01;
& P<0.05, t-test). (b) In sham rats, the predrug (1nmol bethanechol) baseline ﬁring rate was higher in neurons that were inhibited
by bethanecol than the baseline ﬁring rate recorded in neurons from lesioned rats that were also inhibited by the same concentration of
bethanechol (∗P<0.029, t-test). (c) The percent of inhibition evoked by 1nmol bethanechol is higher in neurons recorded in sham rats
than in those recorded in lesioned rats (∗P<0.04, t-test). APP, application time (down arrow); spks/s, spikes per second.
eﬀects in sham rats: in seven out of 13 neurons (54%)
induced a 64.49 ± 27% increase and two neurons (16%)
did not respond. In neurons that increased their ﬁring and
in neurons that did not respond, the baseline ﬁring rate
was 27 ± 3.1 and 22.45 ± 2.3 spikes/s, respectively. In four
neurons (30%) the ﬁring rate diminished by 33 ± 3.4%. The
spontaneous baseline ﬁring rate in neurons that diminished
their ﬁring was 42.73 ± 15.4 spikes/s. Whereas in lesioned
rats, the same dose of oxotremorine produced a 92 ± 12.7%
increase in the baseline ﬁring rate of seven out of 11 neurons
tested (64%). In two out of 11 neurons (18%) oxotremorine
diminished the ﬁring rate by 30.5 ± 2.2%. In the remaining
two neurons (18%) oxotremorine had no eﬀect. There was
a signiﬁcant diﬀerence in the inhibition induced by 1nmol
oxotremorine in both groups of rats (P<0.01, t-test, Table
3).
4. Discussion
Previous works have demonstrated that the GP is innervated
by cholinergic pathways coming from the PPN [17, 18, 20],
a few pallidal neurons that express choline acetyltransferase
together with glutamic acid decarboxylase that weights
67kDa (GAD67) [31], and the presence of MRs in the GP
[21, 22] but there are few studies in which the functional
role of the MRs in GP has been analyzed. Moreover, previous
works have found mRNA for M1 and M4 receptors in
medium spiny striatal neurons and the expression of M1 and
M4 muscarinic receptor proteins in the striatum but have
not detected mRNA for MRs in GP neurons [23–25, 32, 33].
This is the ﬁrst study where the contribution of MRs to
the spiking activity of GP neurons recorded in vivo both
in normal and ipsilateral striatum-lesioned rats is analyzed.The Scientiﬁc World Journal 7
Table 2: Response of GP neurons to 1nmol bethanechol in normal
and ipsilateral striatum-lesioned rats.
Increase Decrease No response Total
Normal 11 (58%) 5 (26%) 3 (16%) 19 (100%)
Lesioned 19 (68%) 4 (14%) 5 (18%) 28 (100%)
Values represent n (%).
Table 3: Response of GP neurons to 1nmol oxotremorine in
normal and ipsilateral striatum-lesioned rats.
Increase Decrease No response Total
Normal 7 (54%) 4 (30%) 2 (16%) 13 (100%)
Lesioned 7 (64%) 2 (18%) 2 (18%) 11 (100%)
Values represent n (%).
Our results indicate that local activation or blockade of MRs
produces heterogeneous eﬀects in the spontaneous spiking
activity of GP neurons of both groups of rats. In the one
hand,innormalrats,theresponseofpallidalneuronsevoked
by activation of MRs depends on the baseline ﬁring rate
before local application of drugs; neurons with high baseline
spiking rates diminish their activity, whereas those with
lowerspikingratesincreasetheiractivityordonotchange.In
the other hand, in pallidal neurons recorded from ipsilateral
striatum-lesioned rats, we did not ﬁnd any relationship
between the basal ﬁring rate before and after activation of
MRs.
We demonstrate the presence of a tonic release of acetyl-
choline in the GP linked to the activity of MRs since if we
block MRs with atropine or inhibit acetylcholinesterase, the
spontaneous spiking rate signiﬁcantly changes in most of the
recording neurons.
Kayadjanian et al. [26] reported that in rat brain slices
the application of a muscarinic agonist increases GABA
release in the GP through phosphoinositides and that the
eﬀect is blocked by a muscarinic antagonist. These results
were attributed to the activation of presynaptic MRs in the
striato-pallidal pathway; however, there is not a direct dem-
onstration of the presence of these receptors in pallidal ter-
minals of medium spiny neurons. In this context, the ac-
tivation of striatal M1 receptors diminishes a variety of cal-
cium conductances including N and P/Q currents in the
dendrites and soma of medium spiny neurons [34]. N and
P/Q currents are associated with neurotransmitter release
through activation of Gq/11-PLC [35, 36]. The functional
role of striatal M4 receptors is yet to be determined [37].
In our work, there were some diﬀerences in the response
of MRs in normal and ipsilateral striatum-lesioned rats. Be-
sides the relationship between the eﬀect and the basal spik-
ing activity previous to the activation of MRs, we found that
(1) the percent of inhibition evoked by the activation of MRs
in normal rats was higher than in lesioned rats and (2) the
number of neurons that were inhibited in lesioned rats was
lower than in normal rats.
Therefore, our data show the contribution of the striato-
pallidal pathway to the responses evoked by local activation
of MRs in the GP. Supporting this hypothesis, the expression
of MRs on GABAergic terminals in many regions of the CNS
is common, but the regulation of GABA release by these
receptors is more complex; for example, Baba et al. [38]h a v e
pointed outthat activation of MRsincreasesGABA releasein
the substantia gelatinosa of the rat spinal horn; Grillner et al.
[39] reported similar results in mesencephalic dopaminergic
nuclei,whileintheratsubfornicalorgan,bethanechol blocks
GABA release [40]; in a similar manner, it has been found
that activation of MRs increases or diminishes GABA release
in the chick lateral spiriform nucleus [41].
In our work, the heterogeneous responses evoked by
activating local MRs in normal and lesioned rats can be
explained according to the diﬀerential segregation of M1 and
M4 receptors in diﬀerent pools of striato-pallidal terminals.
Diﬀerential distribution of MRs in striatal medium spiny
neurons is considerable; 100% of medium spiny enkepha-
linergic neurons express M1 receptors while 30–50% of this
kind of neurons expresses M4 receptors [23, 25]. M1 re-
ceptors diminish GABA release in striatal neurons [34]b u t
the eﬀect of M4 receptors on medium spiny neurons is un-
known, although presynaptic activation of M4 receptors in
the spinal dorsal horn and in the hippocampus increases
GABA release [42, 43].
Nevertheless, the diﬀerential expression of presynaptic
M1 and M4 receptors does not fully explain why in normal
rats exists a direct relationship between the baseline spiking
rate level and the eﬀect caused by the drugs we tested. There
is not an easy explanation of this phenomenon. An idea
would be that in pallidal neurons ﬁring at low frequency,
the striato-pallidal terminals could express M4 receptors
while pallidal neurons with higher spontaneous frequency
could express M1 receptors. Segregation of M1 and M4 re-
ceptors in striato-pallidal terminals could depend on the
basal activity of postsynaptic events. In agreement with this
idea, using triple-whole cell patch-clamp recording from
GABAergic interneurons in the rat insular cortex, it has been
shown that carbachol diminishes or augments the amplitude
of inhibitory postsynaptic currents (IPSCs) activating M1
or M4 receptors in diﬀerent terminals of the same cell.
Expression of M1 or M4 depends on the type of postsynaptic
neuron [44]; furthermore, three diﬀerent types of GP neu-
rons have been characterized based on their membrane
properties [45, 46]. However, we concede that single-unit
extracellular recordings cannot readily diﬀerentiate these
types of neurons. In this context, one could not discard the
expression of MRs in another aﬀerents, like glutamatergic
ﬁberscomingfromthesubthalamicnucleusthatplayamajor
roleinglobuspallidusactivity[47].Further,activationofM3
receptors modiﬁes the activity of subthalamic neurons [48]
b u tM 3r e c e p t o r sa r ee x p r e s s e do na ﬀerents ﬁbers and have
not been detected in subthalamic neurons [49].
Our results show a tonic cholinergic activity in the GP. It
has been shown in preparations similar to ours that neurons
of the PPN ﬁre spontaneously [50, 51]. This spontaneous
activity of PPN neurons would explain the presence of
the tonic cholinergic release into GP reported here. This
cholinergic input could be mediated by MRs as our data on
the local blockade of MRs points out. However, we must
consider that there are few cholinergic neurons in the medial8 The Scientiﬁc World Journal
border of the GP near to the basalis nucleus of Meynert and
that their contribution to the whole GP activity is unknown
[31]. Amacrine cells in the retina corelease GABA and acetyl-
choline but the stimuli and mechanisms involved are quite
complex [52].
Finally, with the destruction of the striato-pallidal ﬁbers,
one would expect an increase in the spiking rate of GP
neurons of lesioned rats [53, 54] but there are no diﬀerences
between the baseline ﬁring rate recorded in sham rats and
that recorded in ipsilateral striatum-lesioned rats; one pos-
sible explanation to this is that chloral hydrate as anesthetic
modiﬁes the GABAergic transmission as compared to locally
anesthetized rats [55]. Despite studies showing the presence
of mRNA for M1 and M4 receptors in striato-pallidal neu-
rons, the location of MRs in pallidal neurons should not be
disregarded; some of the eﬀects reported here could be due
to postsynaptic MRs that until now have not been detected.
5. Conclusion
Our data indicate that MRs homogenize the activity of
pallidal neurons; neurons with high spiking rates diminish
their ﬁring frequency and those with low activity increase it.
Asimilar observation wasmade inthe striatum: activationof
MRsinthestriatumsynchronizestheactivityofensemblesof
diﬀerent groups of medium spiny neurons [56]. The eﬀect of
MRs on GP neurons depends on their basal activity and on
the integrity of the striato-pallidal pathway. Modulation of
MRs in the GP could be a pharmacological target to improve
some motor system alterations.
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